/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

F

Florian Clatot

Laboratoire National Henri Becquerel(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

253

Papers

4.0K

Citations

35

h-index

72

i10-index

Florian Clatot is an academic researcher from Laboratoire National Henri Becquerel. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics. The author has an h-index of 35, co-authored 216 publications.

ORCID: 0000-0002-7074-9282

Research Topics

Cancer Immunotherapy and Biomarkers Breast Cancer Treatment Studies Cancer Genomics and Diagnostics Cancer Cells and Metastasis Head and Neck Cancer Studies

Papers by this author

works

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

2022 · The Lancet Oncology · 291 citations

https://doi.org/10.1016/s1470-2045(22)00555-1

François‐Clément Bidard Anne‐Claire Hardy‐Bessard Florence Dalenc

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

2022 · The Lancet Oncology · 291 citations

https://doi.org/10.1016/s1470-2045(22)00555-1

François‐Clément Bidard Anne‐Claire Hardy‐Bessard Florence Dalenc

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

2021 · ESMO Open · 127 citations

https://doi.org/10.1016/j.esmoop.2021.100114

Thomas Grinda Alison Antoine William Jacot Céline Blaye

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

2017 · British Journal of Cancer · 116 citations

https://doi.org/10.1038/bjc.2017.250

David Sefrioui France Blanchard Emmanuel Touré Paul Basile

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

2018 · Breast Cancer Research · 51 citations

https://doi.org/10.1186/s13058-018-0968-0

Violette Allouchery Ludivine Beaussire Anne Perdrix David Sefrioui

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

2023 · European Journal of Cancer · 48 citations

https://doi.org/10.1016/j.ejca.2022.12.015

Yungan Tao Xu-Shan Sun Y. Pointreau Christophe Le Tourneau

Research topics

topics

Cancer Immunotherapy and Biomarkers

Breast Cancer Treatment Studies

Cancer Genomics and Diagnostics

Cancer Cells and Metastasis

Head and Neck Cancer Studies

Chat about Author

Papers

Chat

Click to start Chat